Cargando…

Dendritic Cells as Vaccines: Key Regulators of Tolerance and Immunity

Detalles Bibliográficos
Autores principales:	Tel, Jurjen, Benitez-Ribas, Daniel, Janssen, Edith M., Smits, Evelien L. J., Jacobs, Joannes F. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906213/ https://www.ncbi.nlm.nih.gov/pubmed/27340343 http://dx.doi.org/10.1155/2016/5789725

Ejemplares similares

CD56 marks human dendritic cell subsets with cytotoxic potential
por: Roothans, Dessie, et al.
Publicado: (2013)

Tumoricidal activity of human dendritic cells
por: Tel, Jurjen, et al.
Publicado: (2014)

Long-lasting multifunctional CD8(+) T cell responses in end-stage melanoma patients can be induced by dendritic cell vaccination
por: Wimmers, Florian, et al.
Publicado: (2015)

Naturally circulating dendritic cells to vaccinate cancer patients
por: Bol, Kalijn F., et al.
Publicado: (2013)

Dendritic cell metabolism: immunity and tolerance
por: Vanherwegen, An-Sofie, et al.
Publicado: (2015)

Dendritic Cells in Tolerance and Immunity against Pathogens
por: Boscardin, Silvia Beatriz, et al.
Publicado: (2016)

Interleukin-15-Induced CD56(+) Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential
por: Anguille, Sébastien, et al.
Publicado: (2012)

Correction: Interleukin-15-Induced CD56(+) Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential
por: Anguille, Sébastien, et al.
Publicado: (2014)

Harnessing human plasmacytoid dendritic cells as professional APCs
por: Tel, Jurjen, et al.
Publicado: (2012)

Integrating Immunology and Microfluidics for Single Immune Cell Analysis
por: Sinha, Nidhi, et al.
Publicado: (2018)

Phenotypical Diversification of Early IFNα-Producing Human Plasmacytoid Dendritic Cells Using Droplet-Based Microfluidics
por: Van Eyndhoven, Laura C., et al.
Publicado: (2021)

Revising immune cell coordination: Origins and importance of single‐cell variation
por: Van Eyndhoven, Laura C., et al.
Publicado: (2022)

Single-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cells
por: Wimmers, Florian, et al.
Publicado: (2018)

Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition
por: Tel, Jurjen, et al.
Publicado: (2016)

DNA Vaccination: Transfection and Activation of Dendritic Cells as Key Events for Immunity
por: Akbari, Omid, et al.
Publicado: (1999)

Efferocytosis: Burying cell corpses to regulate tolerance and immunity
por: Divangahi, Maziar
Publicado: (2015)

Engineering global and local signal generators for probing temporal and spatial cellular signaling dynamics
por: Yang, Haowen, et al.
Publicado: (2023)

Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets
por: Sköld, Annette E., et al.
Publicado: (2015)

Single-cell analysis reveals TLR-induced macrophage heterogeneity and quorum sensing dictate population wide anti-inflammatory feedback in response to LPS
por: Tiemeijer, Bart M., et al.
Publicado: (2023)

Ribonucleic Acid Engineering of Dendritic Cells for Therapeutic Vaccination: Ready ‘N Able to Improve Clinical Outcome?
por: Willemen, Yannick, et al.
Publicado: (2020)

Controlling T-Cell Activation with Synthetic Dendritic Cells Using the Multivalency Effect
por: Hammink, Roel, et al.
Publicado: (2017)

Therapeutic Potential of Tolerogenic Dendritic Cells in IBD: From Animal Models to Clinical Application
por: Cabezón, Raquel, et al.
Publicado: (2013)

Moving Beyond the Mouse: Key New Insight Into Human Colonic Dendritic Cells
por: Denning, Timothy L.
Publicado: (2015)

Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer
por: de Bruijn, Sévérine, et al.
Publicado: (2019)

A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets
por: Sittig, Simone P., et al.
Publicado: (2016)

Lymphatic endothelial cells - key players in regulation of tolerance and immunity
por: Tewalt, Eric F., et al.
Publicado: (2012)

Therapeutic Liposomal Vaccines for Dendritic Cell Activation or Tolerance
por: Nagy, Noémi Anna, et al.
Publicado: (2021)

FOXO3: A master switch for regulating tolerance and immunity in dendritic cells
por: Watkins, Stephanie K., et al.
Publicado: (2012)

Breakdown of Immune Tolerance in Systemic Lupus Erythematosus by Dendritic Cells
por: Liao, Xiaofeng, et al.
Publicado: (2016)

Dendritic Cells: Immune Response in Infectious Diseases and Autoimmunity
por: Sesti-Costa, Renata, et al.
Publicado: (2020)

Tumor-reactive T cells are licensed by dendritic cells located in spatially different tissues: implications for dendritic cell vaccines
por: Santana-Magal, Nadine, et al.
Publicado: (2021)

Harnessing Dendritic Cells for Tumor Antigen Presentation
por: Nierkens, Stefan, et al.
Publicado: (2011)

Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect
por: Jacobs, Julie, et al.
Publicado: (2015)

Immunity and Tolerance Induced by Intestinal Mucosal Dendritic Cells
por: Aliberti, Julio
Publicado: (2016)

Editorial: Harnessing the Participation of Dendritic Cells in Immunity and Tolerance
por: Boscardin, Silvia Beatriz, et al.
Publicado: (2020)

The Dendritic Cell Dilemma in the Skin: Between Tolerance and Immunity
por: Scheib, Nils, et al.
Publicado: (2022)

Dendritic cell vaccination and immune monitoring
por: Aarntzen, E. H. J. G., et al.
Publicado: (2008)

HDL and the golden key to cancer immunity?
por: Plebanek, Michael P., et al.
Publicado: (2018)

Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial
por: Zubizarreta, Irati, et al.
Publicado: (2019)

Dendritic cell-based therapeutic cancer vaccines: past, present and future
por: Ahmed, Md. Selim, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_le9ij7khcpi65c0oc806f9ba0g